Evidence map›Paper›PMID 34108991›Full record

ArticleFrontiers in genetics2021

N

Sara B Fernandes, Nathalie Grova, Sarah Roth, Radu Corneliu Duca, Lode Godderis, Pauline Guebels, Sophie B Mériaux, Andrew I Lumley, Pascaline Bouillaud-Kremarik, Isabelle Ernens and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. The Role of Methylation Modification in Neural Injury and Repair.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Epigenetic modifications of DNA and RNA in Alzheimer's disease.Frontiers in molecular neuroscience · 2024
    Review
  7. Emerging Roles for DNA 6mA and RNA m6A Methylation in Mammalian Genome.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Brominated flame retardants, a cornelian dilemma.Environmental chemistry letters · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. N6-methyladenine: A Rare and Dynamic DNA Mark.Advances in experimental medicine and biology · 2022
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Sara B FernandesImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Nathalie GrovaImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Sarah RothImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Radu Corneliu DucaUnit Environmental Hygiene and Human Biological Monitoring, Department of Health Protection, National Health Laboratory (LNS), Dudelange, Luxembourg.
Lode GodderisCentre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Pauline GuebelsImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Sophie B MériauxImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Andrew I LumleyCardiovascular Research Unit, Department of Public Health, Luxembourg Institute of Health, Strassen, Luxembourg.
Pascaline Bouillaud-KremarikCalbinotox, EA7488, Faculty of Science and Technology, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Isabelle ErnensCardiovascular Research Unit, Department of Public Health, Luxembourg Institute of Health, Strassen, Luxembourg.
Yvan DevauxCardiovascular Research Unit, Department of Public Health, Luxembourg Institute of Health, Strassen, Luxembourg.
Henri SchroederCalbinotox, EA7488, Faculty of Science and Technology, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Jonathan D TurnerImmune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Luxembourg Institute of Health · LUComposés Alimentaires : Biofonctionnalités et risques Neurotoxiques · FREuropean External Action Service · BELaboratoire National de Santé · LUUniversity of Luxembourg · LU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA methylation is one of the most important epigenetic modifications and is closely related with several biological processes such as regulation of gene transcription and the development of non-malignant diseases. The prevailing dogma states that DNA methylation in eukaryotes occurs essentially through 5-methylcytosine (5mC) but recently adenine methylation was also found to be present in eukaryotes. In mouse embryonic stem cells, 6-methyladenine (6mA) was associated with the repression and silencing of genes, particularly in the X-chromosome, known to play an important role in cell fate determination. Here, we have demonstrated that 6mA is a ubiquitous eukaryotic epigenetic modification that is put in place during epigenetically sensitive periods such as embryogenesis and fetal development. In somatic cells there are clear tissue specificity in 6mA levels, with the highest 6mA levels being observed in the brain. In zebrafish, during the first 120 h of embryo development, from a single pluripotent cell to an almost fully formed individual, 6mA levels steadily increase. An identical pattern was observed over embryonic days 7-21 in the mouse. Furthermore, exposure to a neurotoxic environmental pollutant during the same early life period may led to a decrease in the levels of this modification in female rats. The identification of the periods during which 6mA epigenetic marks are put in place increases our understanding of this mammalian epigenetic modification, and raises the possibility that it may be associated with developmental processes.

Indexed as

6-methyladeninebraindevelopmental neurotoxicityDNA methylationembryo developmentstress

Identifiers

PMID34108991
PMCPMC8181416
OpenAlexW3163997797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.